SEC Form 4 · accession 0001104659-18-071150
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yakob Liawatidewi
Officer — SVP Corp Admin Center
Period of report
Nov 30, 2018
Accepted (ET)
Dec 3, 2018 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2018 | M | 11,500 | $20.26 | A | 48,963 | D | |
| Common StockF1 | Nov 30, 2018 | S | 11,500 | $21.4995 | D | 37,463 | D | |
| Common StockF2,F3 | Nov 30, 2018 | S | 2,480 | $21.4795 | D | 6,369 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF4 | $20.26 | Nov 30, 2018 | M | 11,500 | D | — | Aug 5, 2019 | Common Stock | 11,500 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.4401 to $21.524, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (4) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.43 to $21.50, inclusive.
- F3The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
- F4Shares subject to the option are fully vested and immediately exercisable.